Surprisingly, when 25 μg anti–PD-1 antibody was used, we observed a more modest effect on suppressing WT tumor growth, but this dose still largely inhibited ATXN3-KO tumor growth (Figure 5B). Here, ATXN3 is linked to neoplasm.